Capillary Lymphangioma — Clinical Trials

MONDO:00022623 active·2 recruitingLast updated: Mar 19, 2026, 8:49 AM

Trial Landscape

Capillary Lymphangioma has an emerging clinical trial program, driven by drug treatment and gene therapy.

Recruiting

Active Trials

By Approach

Drug Treatment2

Gene Therapy1

By Phase

Phase 2

1 trials are observational or have no phase designation.

Sponsor Types

Academic/Other3

Trial Locations

Italy1 trial

Australia1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT05983159

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

Sponsor:Murdoch Childrens Research Institute

AustraliaStarted: Sep 2024Est. completion: Dec 2026Updated: Feb 2026

Not ApplicableRecruiting

NCT06892964

Institution of an Italian Registry and Biobank for Biological Sample Collection

Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

ItalyStarted: Jun 2024Est. completion: Jun 2044Updated: Mar 2025

Phase 2Not Yet Recruiting

NCT07477548

A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies

Sponsor:Yonsei University

Started: Apr 2026Est. completion: Nov 2030Updated: Mar 2026

Stay informed about clinical trials for Capillary Lymphangioma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 8:49 AM